🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dose escalating study of 7 daily doses of Proellex at 100 mg, 150 mg and 20...
Status
Completed
Location
Healthcare Discoveries Inc.
Start Date
2008-02
Trial ID
NCT00619385
Treatments Being Tested
ZPU-003 EXT is a 2-year extension study of ZPU-003 (NCT00882258) to determi...
Status
Completed
Location
Women's Health Research
Start Date
2006-09-07
Trial ID
NCT00958334
Treatments Being Tested
The purpose of this study is to determine whether Proellex is safe and effe...
Status
Terminated
Location
Advanced Clinical Therapeutics, LLC
Start Date
2007-11
Trial ID
NCT00556075
Treatments Being Tested
Study to evaluate the PK of 25 mg and 50 mg of Proellex from 2 different su...
Status
Completed
Location
Healthcare Discoveries Inc.
Start Date
2008-08-11
Trial ID
NCT00749879
Treatments Being Tested
Two (2) dose levels of Proellex or placebo will be administered once-daily ...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC
Start Date
2006-03
Trial ID
NCT00882258
Treatments Being Tested
The primary objective of this study is to determine the safety and efficacy...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC
Start Date
2015-03-16
Trial ID
NCT02301897
Treatments Being Tested
This study is a double-blind crossover study in female healthy volunteers t...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01962805
Treatments Being Tested
Eligible female subjects will be randomly assigned to one of the three trea...
Status
Terminated
Location
Alabama Clinical Therapeutics
Start Date
2008-06
Trial ID
NCT00702702
Treatments Being Tested
The primary purpose of this study is to determine the safety and efficacy o...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-02
Trial ID
NCT01728454
Treatments Being Tested
This study is a phase 2, open-label extension study of 12 mg Proellex for 2...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT01961908
Treatments Being Tested